Cargando…

Anticancer medicines in China: Trends in daily therapy cost and relative procurement volume and spending

Detalles Bibliográficos
Autores principales:	Huang, Tao, Wagner, Anita Katharina, Bai, Lin, Huang, Cong, Guan, Xiaodong, Shi, Luwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045901/ https://www.ncbi.nlm.nih.gov/pubmed/33609064 http://dx.doi.org/10.1002/cac2.12144

Ejemplares similares

The impacts of government reimbursement negotiation on targeted anticancer medication price, volume and spending in China
por: Zhang, Yichen, et al.
Publicado: (2021)

Impact of National Volume-Based Procurement on the Procurement Volumes and Spending for Antiviral Medications of Hepatitis B Virus
por: Yuan, Jing, et al.
Publicado: (2022)

Trends of Negotiated Targeted Anticancer Medicines Use in China: An Interrupted Time Series Analysis
por: Huang, Cong, et al.
Publicado: (2021)

Monitoring What Governments “Give for” and “Spend on” Vaccine Procurement: Vaccine Procurement Assistance and Vaccine Procurement Baseline
por: Nelson, E. A. S., et al.
Publicado: (2014)

The impact of government reimbursement negotiation on targeted anticancer medicines use and cost in China: A cohort study based on national health insurance data
por: Yang, Yu, et al.
Publicado: (2023)

Influence of Government Price Regulation on the Price, Volume and Spending of Antibiotics in China: A Controlled Interrupted Time Series Study
por: Wushouer, Haishaerjiang, et al.
Publicado: (2020)

Secular trend analysis of antibiotic utilisation in China’s hospitals 2011–2018, a retrospective analysis of procurement data
por: Wushouer, Haishaerjiang, et al.
Publicado: (2020)

Differences in reimbursement listing of anticancer therapies in China: an observational study
por: Guan, Xiaodong, et al.
Publicado: (2020)

Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines?
por: Huang, Cong, et al.
Publicado: (2022)

PSPAB: Privacy-preserving average procurement bidding system with double-spending checking
por: Li, Li, et al.
Publicado: (2020)

Overall survival benefits of cancer drugs in the WHO Model List of Essential Medicines, 2015–2021
por: Zhou, Yue, et al.
Publicado: (2023)

Evidence of clinical benefit of WHO essential anticancer medicines for children, 2011–2021
por: Bai, Lin, et al.
Publicado: (2023)

The impact of “4 + 7” volume-based drug procurement on the volume, expenditures, and daily costs of antihypertensive drugs in Shenzhen, China: an interrupted time series analysis
por: Yang, Ying, et al.
Publicado: (2021)

Health Care Utilization and Costs of Patients With Prostate Cancer in China Based on National Health Insurance Database From 2015 to 2017
por: Bai, Lin, et al.
Publicado: (2020)

Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China
por: Zhang, Yichen, et al.
Publicado: (2022)

Trends in medicines procurement by the Brazilian federal government from 2006 to 2013
por: Chama Borges Luz, Tatiana, et al.
Publicado: (2017)

Improving access to medicines and beyond: the national volume-based procurement policy in China
por: Zhu, Zheng, et al.
Publicado: (2023)

Understanding spending trends for tuberculosis
por: Zwerling, Alice
Publicado: (2020)

The global procurement landscape of leishmaniasis medicines
por: Choi, Hye Lynn, et al.
Publicado: (2021)

European collaborations on medicine and vaccine procurement
por: Vogler, Sabine, et al.
Publicado: (2021)

Factors Influencing Procurement Officers’ Preference for PPP Procurement Model: An Empirical Analysis of China
por: Cao, Fuguo, et al.
Publicado: (2022)

Comparison of Anticancer Medication Use and Spending Under US Oncology Parity Laws With and Without Out-of-Pocket Spending Caps
por: Dusetzina, Stacie B., et al.
Publicado: (2021)

Procurement, storage and utilization trends of eye banks in India
por: Sharma, Namrata, et al.
Publicado: (2019)

Trends in Social Spending by Private Health Insurers
por: Velasquez, David E., et al.
Publicado: (2022)

Medication Use During Pregnancy in Mainland China: A Cross-Sectional Analysis of a National Health Insurance Database
por: Zhang, Jingyuan, et al.
Publicado: (2019)

Psychotropic medication utilisation in adult cancer patients in China: A cross-sectional study based on national health insurance database
por: Bai, Lin, et al.
Publicado: (2020)

Commentary: Procurement, storage and utilization trends of eye banks in India
por: Prajna, N Venkatesh
Publicado: (2019)

Health spending trends in the 1980's: Adjusting to financial incentives
por: Arnett, Ross H., et al.
Publicado: (1985)

Using marginal analysis to evaluate health spending trends
por: Kowalczyk, George I., et al.
Publicado: (1988)

Strategic procurement and international collaboration to improve access to medicines
por: Ferrario, Alessandra, et al.
Publicado: (2017)

Procurement of medicines to treat cancer, 2015–2020, China
por: Pan, Mengyuan, et al.
Publicado: (2022)

Corruption, accountability, and discretion of procurement officials: An analysis of selection Preferences for Performance-based Evaluation Criteria (PBEC) in PPP procurement
por: Cao, Fuguo, et al.
Publicado: (2023)

Pharmaceutical procurement among public sector procurers in CARICOM
por: Preston, Charles, et al.
Publicado: (2021)

CLIC test facility cost evaluation and spending profile
por: Baconnier, Y, et al.
Publicado: (1988)

Cost and Cost-Effectiveness of a Demand Creation Intervention to Increase Uptake of Voluntary Medical Male Circumcision in Tanzania: Spending More to Spend Less
por: Torres-Rueda, Sergio, et al.
Publicado: (2018)

Clinical Outcome and Medical Cost of Originator and Generic Antihypertensive Drugs: A Population-Based Study in Yinzhou, China
por: Huang, Tao, et al.
Publicado: (2022)

Effects of County Public Hospital Reform on Procurement Costs and Volume of Antibiotics: A Quasi-Natural Experiment in Hubei Province, China
por: Tang, Yuqing, et al.
Publicado: (2018)

Procuring Abortion
Publicado: (1850)

The impacts of implementation of National Essential Medicines Policies on primary healthcare institutions: a cross-sectional study in China
por: Guo, Zhigang, et al.
Publicado: (2017)

Influence of government price regulation and deregulation on the price of antineoplastic medications in China: a controlled interrupted time series study
por: Guan, Xiaodong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7hk6ghdc5ehu39c29blblj49ed